A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...

Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully ...

BriaCell Therapeutics (BCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...

New research from the University of Mississippi (UM) indicated that some sugar may benefit you when taking certain ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

Bharath Advanced Therapeutics (BAT), as a key organiser of Cancer NEXT 2024 alongside Nizam's Institute of Medical Sciences (NIMS) and Federation of Asian Biotech Associations (FABA), successfully led ...

In mice, a ketogenic diet remodeled the translatome of pancreatic cancer cells, rendering them vulnerable to targeted therapy ...

Shares of Janux Therapeutics surged after its prostate cancer treatment was selected for expansion trials following what it called encouraging efficacy and safety results.

A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more ...

And it could reduce the harmful side effects of cancer treatment. Instead of a literal spoonful of sugar, however, the ...

Many cancer drugs are antimetabolites, which interfere with the cellular processes necessary for tumor growth and survival.